Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices 6875 

Need and Use of Information 

Collection: The NIDA Summer Research 

Internship program introduces high 

school and undergraduate students of 

underrepresented populations to 

substance abuse research through 

internships with NIDA grantees at 

universities across the United States and 

Puerto Rico. Students intern with NIDA 

principal investigators for 8–10 weeks 

during the summer. The internship 

experience may include laboratory 

experiments, formal courses, data 

collection, data analysis, patient 

recruitment, manuscript preparation, 

literature reviews and library research. 

This outreach and pipeline program 

exposes students interested in 

biomedical and behavioral research 

careers to cutting edge substance abuse 

research. 

This program fills a significant unmet 

need to encourage and support 

individuals from underrepresented 

groups to pursue careers in substance 

abuse research. The NIDA Summer 

Research Internship program offers a 

unique opportunity to increase the 

diversity and creativity of the 

biomedical research workforce by 

fostering the development of young 

talent through the creation of 

mentorship and training opportunities 

with premier substance abuse research 

laboratories around the country. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

350. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

Application Form ............................... High School Students ....................... 100 1 1 100 

Application Form ............................... Undergraduates ................................ 250 1 1 250 

Dated: February 2, 2016. 

Genevieve DeAlmeida-Morris, 

Project Clearance Liaison, NIDA, NIH. 

[FR Doc. 2016–02446 Filed 2–8–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Inherited 

Disease Research Access Committee. 

Date: March 4, 2016. 

Time: 11:30 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Suite 

3049, 5635 Fishers Lane, Bethesda, MD 

20892, (Telephone Conference Call). 

Contact Person: Barbara J Thomas, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2218, 

MSC 7890, Bethesda, MD 20892, 301–435– 

0603, bthomas@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: February 4, 2016. 

Sylvia Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–02537 Filed 2–8–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Heart, Lung, and 

Blood Initial Review Group; Clinical Trials 

Review Committee. 

Date: March 3–4, 2016. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Keary A. Cope, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, 6701 Rockledge Drive, Room 

7190, Bethesda, MD 20892–7924, 301–435– 

2222, copeka@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: February 3, 2016. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–02456 Filed 2–8–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

grant applications and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

mstockstill on DSK4VPTVN1PROD with NOTICES

6876 Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices 

associated with the grant applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Transcatheter Cavopulmonary Bypass 

Endograft. 

Date: March 2, 2016. 

Time: 9:30 a.m. to 12:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Room 7182, Bethesda, MD 

20892, (Telephone Conference Call). 

Contact Person: Susan Wohler Sunnarborg, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review/DERA, National, Heart, 

Lung, and Blood Institute, 6701 Rockledge 

Drive, Room 7182, Bethesda, MD 20892, 

sunnarborgsw@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Career Development Program to Promote 

Diversity in Health Research. 

Date: March 4, 2016. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The River Inn, 924 25th Street NW., 

Washington, DC 20037. 

Contact Person: Stephanie L. Constant, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review/DERA, National Heart, 

Lung, and Blood Institute, 6701 Rockledge 

Drive, Room 7189, Bethesda, MD 20892, 301– 

443–8784, constantsl@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: February 3, 2016. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–02458 Filed 2–8–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Neurogenesis and 

Cell Fate Study Section, February 18, 

2016, 08:00 a.m. to February 19, 2016, 

02:00 p.m., Hotel Kabuki, 1625 Post 

Street, San Francisco, CA, 94115 which 

was published in the Federal Register 

on January 26, 2016, 81 FR 4316–4317. 

The meeting will be held on February 

18, 2016 from 8:00 a.m.–8:00 p.m. The 

meeting location remains the same. The 

meeting is closed to the public. 

Dated: February 3, 2016. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–02455 Filed 2–8–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; BD2K RFAs: 

Courses for Skills Development and Open 

Educational Resources for Biomedical Big 

Data (R25). 

Date: March 2, 2016. 

Time: 12:00 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Kee Hyang Pyon, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5148, 

MSC 7806, Bethesda, MD 20892, 

pyonkh2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Oncology. 

Date: March 3–4, 2016. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Juraj Bies, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Dr., Rm. 4158, MSC 7806, Bethesda, MD 

20892, 301–435–1256, biesj@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR 12– 

251: Behavioral Science Track Award for 

Rapid Transition Review. 

Date: March 3, 2016. 

Time: 11:30 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Serena Chu, Ph.D., 

Scientific Review Officer, BBBP IRG, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3178, 

MSC 7848, Bethesda, MD 20892, 301–500– 

5829, sechu@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 3, 2016. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–02454 Filed 2–8–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; Drug 

Accountability Report Form and 

Investigator Registration Procedure in 

the Conduct of Investigational Trials 

for the Treatment of Cancer (NCI) 

SUMMARY: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Cancer Institute, the National Institutes 

of Health, has submitted to the Office of 

Management and Budget (OMB) a 

request for review and approval of the 

information collection listed below. 

This proposed information collection 

was previously published in the Federal 

Register on November 17, 2015 page 

71815 and allowed 60 days for public 

comment. No public comments were 

received. The purpose of this notice is 

to allow an additional 30 days for public 

comment. The National Cancer Institute, 

National Institutes of Health, may not 

conduct or sponsor, and the respondent 

is not required to respond to, an 

information collection that has been 

extended, revised, or implemented on or 

after October 1, 1995, unless it displays 

a currently valid OMB control number. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974, Attention: NIH 

Desk Officer. 

mstockstill on DSK4VPTVN1PROD with NOTICES